Tag: Schizophrenia

Stock

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY ® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New

30/05/2025
admin

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY ® (risperidone) Showing Lower Rates…

Stock

Nxera Pharma Notes Neurocrine Biosciences Presents New Positive Data from Phase 2 Study of NBI-1117568 in Adults with Schizophrenia at American Society of Clinical Psychopharmacology 2025

28/05/2025
admin

Nxera Pharma Notes Neurocrine Biosciences Presents New Positive Data from Phase 2 Study of NBI-1117568 in…